These results provide compelling evidence that semaglutide reduces ASCVD risk also in patients with obesity and established ASCVD but not T2D, laying groundwork for novel therapeutic strategies for the treatment of obesity in people with high risk for CV events
A novel anti-inflammatory mechanism
465 This modulatory effect holds promise for ameliorating sympathetic activity in individuals with hypertension, as these agents lower blood pressure levels
These experiments demonstrate that modulating OB Glp1r -expressing neuron activity can bidirectionally influence food intake
Ann Pediatr Endocrinol Metab
Often, small adjustments, such as eating smaller meals, choosing easy-to-digest foods, staying hydrated, or reducing greasy or spicy foods, can make a noticeable difference